{"name":"Verismo Therapeutics","slug":"verismo-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi-wFBVV95cUxPc1pjaFNNQU1iaW15aXl5Wk5yU3dRZWdHUDBsZFFVQlFVQXpQOG1pZFMyejh3aXZySGwtVmpfVm91WnhxbGEzVF9nWExuX3ZkbF9oaENndDA0bVprd0pQYktXSlJ6YmlCWXNzd0JMMFB4Ul9YMWlrTW1Zb3FMcGNmS0h1RnNsaDYwOXBudlpHaER3aTdlSFJwekYxdGtwbU82ZHhYWXVSWGQ1WFJ1bl94R2x5ZUU2Qm1SeEZla3VOUEhMb2o4dllEX3VOVFl3UmFzQkxvWlhGYWd2THZGdWdfckcyM3lTeFdScFlOQlJ4Q19lTll5cm9fSWJfQQ?oc=5","date":"2026-01-29","type":"pipeline","source":"globenewswire.com","summary":"Elevar Therapeutics Names Dong-Gun Kim CEO as It Focuses on Post-NDA Commercialization Strategy - globenewswire.com","headline":"Elevar Therapeutics Names Dong-Gun Kim CEO as It Focuses on Post-NDA Commercialization Strategy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPN1hQUEZISk0zXzF4Rk9NUTdUVUJJcTBpUWttQXBhSmZ0b3ZKdVMxZUNJdllhNEs1RDVFeE9lOE9oX1ZiSUlyaTljTjRqemphRVJFa1JjTVpWVlRreFdrNW12c0w4bGtGOHBvQ09TSEZ0RkFOcEZ4ZmQwNGRiNkhRMFBLSTczTlA0OENMV3hmZms3UzZoV1B0X012SC13bEp3QklR?oc=5","date":"2025-08-15","type":"deal","source":"Fierce Pharma","summary":"Fierce Pharma Asia—Padcev's new breakthrough; China Alzheimer's drug's fate; Fosun's DPP1 deal - Fierce Pharma","headline":"Fierce Pharma Asia—Padcev's new breakthrough; China Alzheimer's drug's fate; Fosun's DPP1 deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiV0FVX3lxTFBnT0Z4ZVh5RngtZFZoUjAzYUZOVmNnMjFqVl9IcWdiQ2Faa1VKTHR2Vi0tWDk3dkZTZVpELURWR2NLdnBubE9rcm9qVHlDSVdWMVZkNG9Ocw?oc=5","date":"2025-08-13","type":"pipeline","source":"The Korea Herald","summary":"HLB appoints Brian Kim as CEO of US subsidiary Elevar Therapeutics - The Korea Herald","headline":"HLB appoints Brian Kim as CEO of US subsidiary Elevar Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxQeVNPS2VuREdhbHpnSkZkNmJ2ZzVGUEhqN29FcGp0ZGlnOHNwUE95eEhHRERWYU5KUFVJT1FBMG9mVS1tN1JnQWV5VDdSWlNWa25nNUVuMkVSeTVFMlhiRU9Td0tKaE40X2g3OThHYlBFWDV6b0MxX2lJTzJiam9peDV0V25meXUxOTRTVWQ0aDFmZ0RfWFBDejI0S0c5RF9tZk9jYi03bkdHbnNaTVh2SVpYSVNkLUhnNmx4dGdpaXBHRzhPOUZHZFlfeDZPT1JHWGRRb2s5N0VxWHRkZUE?oc=5","date":"2025-01-08","type":"pipeline","source":"BioPharma APAC","summary":"Verismo Therapeutics Secures $4.05M Investment from IFLI to Advance SynKIR™-310 for Follicular Lymphoma - BioPharma APAC","headline":"Verismo Therapeutics Secures $4.05M Investment from IFLI to Advance SynKIR™-310 for Follicular Lymphoma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBuTHlaWmM0Z25NWXpCOXRKb3Y0SmRrVjh1WWY0VnhyM1dWaTNUY0hNVUhXNWxqYlZzbVdGN0I2UWZxdmJFQmpYQ3pBRnVOcE9BOGtIWTl2eEFRdDAzMk96dFdnMDZCUXFNb080Nk9n0gFyQVVfeXFMT0dzX3JKTG9mbFdZcklIOE5RcHBnd2R4QzQ5dGl0bDJvNUdkQUU5TmRXdllXa1VxbEJxQjFLNFhBZlZJZE5kR1FVS1NWdHVpRXdoam1GNnNidFo2eGZMOE5PdE43N1ItNlFRN3RpeE5wVXdn?oc=5","date":"2025-01-08","type":"pipeline","source":"koreabiomed.com","summary":"Verismo draws $4 million to speed up developing small cell lymphoma drug - koreabiomed.com","headline":"Verismo draws $4 million to speed up developing small cell lymphoma drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgJBVV95cUxQLUdGNExlVk1Yb25WMVhZWUlQUzgteV93WGRaSHU4WWZzMDFUYURLQXV5dFdHM3JTcERzSVQ5eUlLOFRSTXFsak8xdFJ4RmpHblB6YXJWY0tXMnhrQWluUk5OTkRqWTZvWHB0UkUyMndISW9XSS1tNDhnTDVnZmVxZm1lWUVLM3VVb2Y0dzJ2ZDExNWlhNk84RERxRkJSY2RubzhfSHZPZ3JpQ1NhSWV3ODltTlc3TF9ZWlV4LXFNWV9EdFlOT1RQNnFGeVotT3l3LWhmd2Z1Y19DcmtfQzJqdDlSaFlsZWJhWmlPMVluVkIzTmRPcTQxcDZ1UkhicGVfQUFqZ3QtZHVfTEQ1RXB4UmFkVkRmeXduUU1XQzM2YU5Jb002cnNpb01B?oc=5","date":"2024-11-28","type":"trial","source":"PR Newswire","summary":"Follicular Lymphoma Clinical Trial Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - PR Newswire","headline":"Follicular Lymphoma Clinical Trial Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Therape","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgJBVV95cUxNOFdoWWVHYVVuZEZuZnlsd1BDMVAtdTBOQXB0T1VkeXpkVG1mU3pBcHg4V1hVakJ4ZUtkSHU0Z0pzSjdZMk9tYUswNTB5alpvcHFsYXNLZG5MMm9LdHpEYmNla1FzdVZ5cGxYUDhkT3ZUNTFOOTZwREc3Q041ZE1rdFhjamMyOVB3MHE3cTFlMXhBWEVvUG5Ubk5hZVlNMWpySHpJUzl2Q1RuTUc5dEJJMmhOQXJjZXF1QmRzdDlNSVJKSlgwenBRYXRXMlFRb1JPTlhsRjRadFJVRkpiUGRwblEySjRCNHRGYjRLc3dId0c5dWJoS1hpZ0EyNzNlQXZNZzl1czdaSmFtVEQ2OHR0b05FSnp4UFBIYXc?oc=5","date":"2023-10-10","type":"pipeline","source":"marketscreener.com","summary":"Verismo Therapeutics, Inc. announced that it expects to receive KRW 12.138369345 billion in funding from HLB Pharmaceutical Co., Ltd - marketscreener.com","headline":"Verismo Therapeutics, Inc. announced that it expects to receive KRW 12.138369345 billion in funding from HLB Pharmaceuti","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxPNHV1dU0ybjMzcDZyZnJVM2t4QzNVZVotZG9YOElQaE5mVzRnNWVpOWZsVVliYmFyUzE1Q1ltd0hXbDBFc3FnWkVCREMtWmg2dzFMNzFXTmQ4eDEtRG1qdjI4TTV0T29kVlRraS1xSnd2aVVMZDE1Umw5b2ZTR21vcTg2bEQ4bHI1cXc?oc=5","date":"2023-04-06","type":"regulatory","source":"Pharmaceutical Technology","summary":"Verismo Therapeutics’ SynKIR-110 receives fast track designation from FDA - Pharmaceutical Technology","headline":"Verismo Therapeutics’ SynKIR-110 receives fast track designation from FDA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxNdzV6aGc5UDlFZVpNMFdUYWF4ZFBuMHl5WVRTYTJHUTBpM3dkTHR5QVI3SnRYS0xDbDExY3R2SWlXaXNuYWhONEtYX19SSjRIdG5Uc29jWVFxRmFaeFZGYlBTSWdIMXB1YXB2VzRGSmVjeldGX3BQeWlqVTA2QmpyX3JkaHBnU3hxVnc5UzhYNWR4WUJsTWthME1sbTNSU2NFWE1DMFFhZ2hIcTV5WlFTVm02YkRjdzJDSno5OEFTUEI4VVIzSU5BLTZFZWd1dlB4Sno4OHpLQXJtLS1vR25Cci10aC1iQjVLTUE?oc=5","date":"2023-02-28","type":"pipeline","source":"PR Newswire","summary":"Verismo Therapeutics Announces $7 Million Pre-Series A with BRV Capital Management as Lead Investor - PR Newswire","headline":"Verismo Therapeutics Announces $7 Million Pre-Series A with BRV Capital Management as Lead Investor","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNcnJuMXFYTlhmTjJWWXBLd09Ya3Rvdk1fWjdJWG5xMVlMSmZHSFZJS0ZaeVl0TFBtMmtiTGg0QkNoMXUzQjRrU1VRSFpIV0NBQjhuOHNESmpGTXpCVEo3Si10YzFVaDlpY0RDYnRBb1Z3eTVxbVhSTk1PeUp1N2xYRHRpcnBCVWNkMm1KT3cxejBaOXhhWnZDUnl3MDJGSGtvNElZTk8zWlVKZEpJNXZvVHYyTzI?oc=5","date":"2021-12-15","type":"pipeline","source":"Fierce Biotech","summary":"Biopharma charts progress in translating CAR-T cell therapies to solid cancers - Fierce Biotech","headline":"Biopharma charts progress in translating CAR-T cell therapies to solid cancers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQa1JLMk1DUFNmUzVzWFVScWtMWTNWQnRUclBnWjZKVzdnamwwTFJOZUdYZmhvS29yaG5XRkR0Z3phYVR2RV9UR2ktNDNseWNQWUhBQXVJd3haSGE4aGkyQzJyWnNtQmVCUEZrZWtpNmtaN3pNVzJkVE52UGVLRzNjajhhQnhRNWFBSEUyVGJjemxMVjF1bENybk1KM3J4Mml5YkxMMGh5YTM3elFLNnNvcHAySnl3Zw?oc=5","date":"2021-10-13","type":"pipeline","source":"citybiz","summary":"Verismo Therapeutics Appoints Laura Johnson, Ph.D. as Chief Scientific Officer - citybiz","headline":"Verismo Therapeutics Appoints Laura Johnson, Ph.D. as Chief Scientific Officer","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}